Wealthcreatures.com
Majesco Cmp :821 Accumulate :800-825 SL : 735 T-1000
MAJESCO
New 52wk HIGH
908
New 52wk HIGH
908
Wealthcreatures.com
KEEP ON RADAR EXPLEO SOLUTION OUR OLD PICK ACCMULATION- 270- 280 ZONE CAN TEST 450/500/600+ TF - 9 TO 12 MONTHS
LATE UPDATE
💎EXPLEO 💎
Up 10%
591
181 TO 591 DONE TILL NOW
3.5X RETURNS TILL NOW
EXPECTING 1⃣0⃣0⃣0⃣++ in BXT 3 TO 4 QTRS
💎EXPLEO 💎
Up 10%
591
181 TO 591 DONE TILL NOW
3.5X RETURNS TILL NOW
EXPECTING 1⃣0⃣0⃣0⃣++ in BXT 3 TO 4 QTRS
Wealthcreatures.com
AARTI DRUGS CAN SEE SOME PROFIT BOOKING AS BONUS SHARES GETTING CREDITED IN NEXT 1 TO 3 DAYS. STOCK ALSO HAD SUPERB RUN UP IN LAST 10 DAYS AFT A SMALL DIP AGAIN UPMOVE TO START AS EXCELLENT Q2 EXPECTED
AARTI DRUGS
GETTING READY FOR U TURN
STOCK ALREADY CORRECTED 22% FROM HIGHS
SUPPORT - 790/750
GETTING READY FOR U TURN
STOCK ALREADY CORRECTED 22% FROM HIGHS
SUPPORT - 790/750
MASTEK & MAJESCO
GOOD ACCMULATION & CONSOLIDATION GOING ON FROM PAST FEW DAYS
GETTING READY FOR BIG UPMOVE IN COMING DAYS
GOOD ACCMULATION & CONSOLIDATION GOING ON FROM PAST FEW DAYS
GETTING READY FOR BIG UPMOVE IN COMING DAYS
Wealthcreatures.com
LATE UPDATE 💎EXPLEO 💎 Up 10% 591 181 TO 591 DONE TILL NOW 3.5X RETURNS TILL NOW EXPECTING 1⃣0⃣0⃣0⃣++ in BXT 3 TO 4 QTRS
EXPLEO
AGAIN NEW ALL TIME HIGH
642 💚💚
181 TO 642 DONE TILL NOW
AGAIN NEW ALL TIME HIGH
642 💚💚
181 TO 642 DONE TILL NOW
API STOCK WHERE GOOD Q2 NUMBERS ARE EXPECTED
KOPRAN
AARTI DRUGS
LAURUS LAB
SOLORA ACTIVE PHARMA
MANGALAM DRUGS
IND SWIFT LAB
GRANULES
KOPRAN
AARTI DRUGS
LAURUS LAB
SOLORA ACTIVE PHARMA
MANGALAM DRUGS
IND SWIFT LAB
GRANULES
Wealthcreatures.com
BSOFT BLASTING 10% 198 167 TO 198 DONE TILL NOW 20% RETURNS WITHIN A WEEK NEW TEST LEVELS # 210/225++ KEEP TRAILING & KEEP BOOKING PROFITS AS PER RISK
BSOFT
LOOKING GOOD AFTER CONSOLIDATION
STOCK READY TO CROSS NEW 52wk HIGH VERY SOON
LOOKING GOOD AFTER CONSOLIDATION
STOCK READY TO CROSS NEW 52wk HIGH VERY SOON
Wealthcreatures.com
KOPRAN NEW 52wk HIGH 95 ONCE CROSSED 101 WE CAN SEE GOOD UPSIDE
KOPRAN
READY TO CROSS 101
BIG UPMOVE IF CLOSED ABOVE 101
CAN TEST - 120/130++
READY TO CROSS 101
BIG UPMOVE IF CLOSED ABOVE 101
CAN TEST - 120/130++
Wealthcreatures.com
Majesco Update. Upper circuit 💚💚 Enjoy.. Hold tight
Majesco
900
💚💚💚💚
💰💰💰
900
💚💚💚💚
💰💰💰
https://wealthcreatures.com/2020/04/13/sbi-cards-only-listed-player-in-credit-available-33-below-ipo-price-value-buy-or-more-pain-coming/
SBI CARDS
NEW 52wk HIGH
873
501 TO 873
DONE TILL NOW
1000 WE CAN SEE IN 2020 ONLY.
POSSIBLE TEST LEVELS FOR INVESTMENT
1000/1250/1500+
SBI CARDS
NEW 52wk HIGH
873
501 TO 873
DONE TILL NOW
1000 WE CAN SEE IN 2020 ONLY.
POSSIBLE TEST LEVELS FOR INVESTMENT
1000/1250/1500+
WealthCreatures
SBI Cards – Only Listed Player in Credit – Available 34% Below IPO price – Value Buy or More pain Coming??
💢 SBI CARDS & PAYMENT SERVICES 💢 Cmp – 501 IPO PRICE – 755 MARKET CAP – 47400 crBOOK VALUE – 3952wk HIGH/LOW -769/5105 Year HIGH/LOW – N.AFACE VALUE – 10 DIV…
Wealthcreatures.com
AARTI DRUGS GETTING READY FOR U TURN STOCK ALREADY CORRECTED 22% FROM HIGHS SUPPORT - 790/750
AARTI DRUGS TO MOVE IN BWT 790/750 TO 875 FOR NEXT FEW DAYS
RESISTANCE- 900/925
ONCE CLOSED ABOVE 930 WE CAN SEE FRESH LEG OF RALLY AND NEW HIGH
ONLY AFTER DECLERATION OF RESULTS DATE STOCK CAN SEE UPWARD MOVEMENT
AROUND & AFTER Q2 NUMBERS STOCK CAN CROSS ITS ALL TIME HIGH WITH VOLUMES
RESISTANCE- 900/925
ONCE CLOSED ABOVE 930 WE CAN SEE FRESH LEG OF RALLY AND NEW HIGH
ONLY AFTER DECLERATION OF RESULTS DATE STOCK CAN SEE UPWARD MOVEMENT
AROUND & AFTER Q2 NUMBERS STOCK CAN CROSS ITS ALL TIME HIGH WITH VOLUMES
Wealthcreatures.com
RSYSTEM INTL CMP - 118/119 ACCMULATE - 110 TO 119 SUPPORT @ 100/98 ONCE CLOSED ABOVE 123 CAN SEE CLEAN UPMOVE MEDIUM TERM(1 TO 3 MONTH) TEST LEVELS # 130/144/150++ LONGTERM TEST LEVELS # 175/190/240++ S/L - 3% Below support Levels or 95 on cbsl
RSYSTEM
AGAIN AVAILABLE AT
117/118
Don't miss I.T
READY FOR NEW HIGH SOON
OUR LONGTERM PAISA DOUBLE STOCK
AGAIN AVAILABLE AT
117/118
Don't miss I.T
READY FOR NEW HIGH SOON
OUR LONGTERM PAISA DOUBLE STOCK
Wealthcreatures.com
XELPMOC 153 TO 355 NOW LOWER CIRCUIT @ 322 TAKING BREATHER & RETRACEMENT AS EXPECTED CAN SEE 3 TO 5 LOWER CIRCUITS BEFORE NEXT LEG OF RALLY RESUMES
XELPMOC
TODAY 5th LOWER CIRCUIT
EXPECTED 3 TO 4 MORE LOWER CURCUIT IN COMING DAYS
DONT JUMP AT CMP
LET STOCK SETTLE
WE WOULD UPDATE WHEN TO ADD
TODAY 5th LOWER CIRCUIT
EXPECTED 3 TO 4 MORE LOWER CURCUIT IN COMING DAYS
DONT JUMP AT CMP
LET STOCK SETTLE
WE WOULD UPDATE WHEN TO ADD
KOPRAN
NeW 52wk HIGH
SUPERB BREAKOUT AFT CONSOLIDATION
ALREADY GAVE UPDATE IN MRNG@100
NOW 102.95 💥💥
NEW TEST LEVELS # 120/130++
OUR LONGTERM Test LEVELS # 250/300++
WE GAVE 1st call@ 36
STOCK ALREADY MULTIBAGGER AND READY FOR 3X
NeW 52wk HIGH
SUPERB BREAKOUT AFT CONSOLIDATION
ALREADY GAVE UPDATE IN MRNG@100
NOW 102.95 💥💥
NEW TEST LEVELS # 120/130++
OUR LONGTERM Test LEVELS # 250/300++
WE GAVE 1st call@ 36
STOCK ALREADY MULTIBAGGER AND READY FOR 3X
LMW
(LAKSHMI MACHINERY WORKS)
Cmp - 3910
BEST BUY - 3850 - 3880
S/L - 3750
TEST LEVEL # 4000/4150/4300++
TF - 1 TO 2 MONTH
LONGTERM TEST LEVELS - 5500/6800++
(LAKSHMI MACHINERY WORKS)
Cmp - 3910
BEST BUY - 3850 - 3880
S/L - 3750
TEST LEVEL # 4000/4150/4300++
TF - 1 TO 2 MONTH
LONGTERM TEST LEVELS - 5500/6800++
INFOSYS RESULTS UPDATE & HIGHLIGHTS :
🎯 Infosys reported 20.50 per cent year-on-year (YoY) rise in net profit at Rs 4,845 crore for the quarter ended September 30 as compared to
Rs 4,019 crore in the corresponding quarter last year.
🎯 Revenue rose 3.82% over the previous quarter to Rs 24,570 crore—higher than the estimated Rs 24,131 crore.
🎯 In dollar terms, the company's revenue increased by 3.2 per cent YoY and 6.12 per cent QoQ to $3,312 million.
🎯 In dollar terms, operating profit stood at $840 million, up 20.7% YoY and 18.7%QoQ.
🎯 EPS increased 14.90 per cent YoY and 17% QoQ to $0.15.
🎯 Consolidated revenue grew 8.60% YoY to Rs 24,570 crore.
🎯 Infosys declared an interim dividend of ₹12 per equity share.
🎯 Infosys also revised its FY21 operating margin guidance upward to 23-24 per cent.
IMPACT
🎯 Reported solid numbers, we may see positive momentum in the stock.
Technical Outlook
🎯 Technically Infosys is in a bullish trend and trading near to lifetime high. In the last trading session, we saw profit booking in it from the higher levels, but in the short term, we can expect further upside movement in it and it can test the major psychological level of 1200 on the upside.
🎯 Infosys reported 20.50 per cent year-on-year (YoY) rise in net profit at Rs 4,845 crore for the quarter ended September 30 as compared to
Rs 4,019 crore in the corresponding quarter last year.
🎯 Revenue rose 3.82% over the previous quarter to Rs 24,570 crore—higher than the estimated Rs 24,131 crore.
🎯 In dollar terms, the company's revenue increased by 3.2 per cent YoY and 6.12 per cent QoQ to $3,312 million.
🎯 In dollar terms, operating profit stood at $840 million, up 20.7% YoY and 18.7%QoQ.
🎯 EPS increased 14.90 per cent YoY and 17% QoQ to $0.15.
🎯 Consolidated revenue grew 8.60% YoY to Rs 24,570 crore.
🎯 Infosys declared an interim dividend of ₹12 per equity share.
🎯 Infosys also revised its FY21 operating margin guidance upward to 23-24 per cent.
IMPACT
🎯 Reported solid numbers, we may see positive momentum in the stock.
Technical Outlook
🎯 Technically Infosys is in a bullish trend and trading near to lifetime high. In the last trading session, we saw profit booking in it from the higher levels, but in the short term, we can expect further upside movement in it and it can test the major psychological level of 1200 on the upside.
REALTY STOCKS IN FOCUS AFT GOVT GAVE BOOST REAL ESTATE FOR AFFORDABLE HOUSING PROJECTS # STOCKS IN FOCUS # GODREJ PROPERTIES,JAI CORP, BOMBAY DEYING,AJMERA REALTY,KOLTE PATIL & SUNTEK REALTY
EXIBITION CENTERS OPENING IN UNLOCK 5.0 # NESCO IN FOCUS
ACTION TO CONTINUE IN MIDCAPS & SMALLCAP
EXIBITION CENTERS OPENING IN UNLOCK 5.0 # NESCO IN FOCUS
ACTION TO CONTINUE IN MIDCAPS & SMALLCAP